End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.18 CNY | +0.09% | +5.77% | +0.09% |
Feb. 20 | Meheco's Unit Gets Nod to Raise Specifications for Piperacillin Sodium for Injection | MT |
Feb. 20 | Argatroban Injection of Meheco's Subsidiary Passes Chinese Drug Regulator's Evaluation | MT |
Sales 2021 | 36.23B 5B | Sales 2022 | 37.59B 5.19B | Capitalization | 25.77B 3.56B |
---|---|---|---|---|---|
Net income 2021 | 647M 89.37M | Net income 2022 | 736M 102M | EV / Sales 2021 | 0.4 x |
Net Debt 2021 | 1.88B 260M | Net Debt 2022 | 1.09B 150M | EV / Sales 2022 | 0.71 x |
P/E ratio 2021 |
19.5
x | P/E ratio 2022 |
35
x | Employees | 8,313 |
Yield 2021 |
1.54% | Yield 2022 |
0.86% | Free-Float | 44.6% |
1 day | +0.09% | ||
1 week | +5.77% | ||
Current month | +1.54% | ||
1 month | -1.15% | ||
3 months | +7.71% | ||
6 months | -3.45% | ||
Current year | +0.09% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Dong Hu
CEO | Chief Executive Officer | 48 | 21-09-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Min Zhang
BRD | Director/Board Member | 62 | 22-08-17 |
Yong Qiang
CHM | Chairman | 58 | 09-09-14 |
Shao Feng Zhang
BRD | Director/Board Member | 46 | Dec. 20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 2 M€ | -20.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 11.18 | +0.09% | 13,895,680 |
24-04-18 | 11.17 | -1.24% | 21,645,630 |
24-04-17 | 11.31 | +2.17% | 33,553,570 |
24-04-16 | 11.07 | +2.50% | 37,024,470 |
24-04-15 | 10.8 | +2.18% | 13,252,970 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+0.09% | 2.31B | |
+13.36% | 68.97B | |
+7.33% | 26.32B | |
+6.34% | 8.13B | |
-2.79% | 7.92B | |
-24.02% | 7.61B | |
+21.83% | 4.49B | |
-2.28% | 3.95B | |
-3.51% | 3.85B | |
+25.02% | 3.73B |
- Stock Market
- Equities
- 600056 Stock